117 results on '"A. Camuglia"'
Search Results
2. 30-Day Outcomes With the Portico Transcatheter Heart Valve: Insights From a Multi-Centre Australian Observational Study
3. Operator and Institutional Requirements for Transcatheter Mitral Valve Therapies in Australia: a CSANZ and ANZSCTS Position Statement
4. Drug-Eluting Stents Versus Coronary Artery Bypass Grafts for Left Main Coronary Disease: A Meta-Analysis and Review of Randomised Controlled Trials
5. Assessment of coronary artery disease with fractional flow reserve in patients with aortic stenosis undergoing transcatheter aortic valve implantation
6. Transcatheter Aortic Valve Replacement is Associated with Comparable Clinical Outcomes to Open Aortic Valve Surgery but with a Reduced Length of In-Patient Hospital Stay: A Systematic Review and Meta-Analysis of Randomised Trials
7. Impact of N-acetylcysteine on Endothelial Function, B-type Natriuretic Peptide and Renal Function in Patients with the Cardiorenal Syndrome: A Pilot Cross Over Randomised Controlled Trial
8. Incidence and Temporal Trends in Permanent Pacemaker Implantation (PPI) Following Transcatheter Aortic Valve Replacement (TAVR)
9. Expanding Treatment Options: Successful UNICORN Procedure with Self-Expanding Valves in Complex Transcatheter Aortic Valve Replacements
10. Characteristics and Outcomes of Patients Who Underwent CABG After Primary PCI for STEMI—A Tertiary Hospital Experience
11. Case Report: Intrapericardial Fibrinolysis for Management of Acute Nonpurulent Pericarditis Complicated by Large Multiloculated Pericardial Effusion
12. Single Antiplatelet Therapy (SAPT) Versus Dual Antiplatelet Therapy (DAPT) in Patients With Transcatheter Aortic Valve Replacement (TAVR): The Australasian Experience.
13. Safety and Success of Procedural Sedation for Invasive Coronary Procedures
14. Chronic Kidney Disease (CKD) and Transcatheter Aortic Valve Replacement (TAVR) in Australasia
15. Anticoagulation With or Without Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement (TAVR): The Verdict From the Australasian Cardiac Outcomes Registry
16. Use of Non-Invasive Coronary Artery Assessment in Transcatheter Aortic Valve Replacement
17. Angiographic Findings in Patients With De Novo Heart Failure With Reduced Ejection Fraction (HFrEF) Referred for Early Inpatient Coronary Angiography During Their Index Admission
18. Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing
19. 30-Day Outcomes With the Portico™ Transcatheter Heart Valve: Insights From a Multi-Centre Australian Observational Study
20. Use of Non-Invasive Coronary Artery Assessment in Transcatheter Aortic Valve Replacement, A Feasibility Study
21. 1-Year Outcome of Hybrid Model of TAVR at a Queensland Centre
22. Echocardiographic “Guidance” During Transcatheter Aortic Valve Replacement (TAVR) – Does Intraprocedural Transoesophageal Echocardiography (TOE) add any Value or Should “Minimalist” Transthoracic Echocardiography (TTE) be the Norm?
23. Can we Better Predict the “True” Left Ventricular Outflow Tract Diameter (LVOTd) for Aortic Valve Area (AVA) Calculation by Transthoracic Echocardiography (TTE)—Strengthening the Chain Through 3D?
24. 902 Time to First Device Time in ST Elevation Myocardial Infarction (STEMI) at a High-Volume STEMI Centre Stratified by Access Site Approach
25. 875 Re-Examining the Obesity Paradox in Women and Men Undergoing PCI
26. 817 Differential Impact of Radial Versus Femoral Access on One-Year Outcomes in Women and Men Undergoing PCI
27. 789 Are There Sex Differences in Outcomes of Patients With Chronic Kidney Disease Undergoing PCI?
28. 281 Accuracy of the E/e’ Ratio as a Measure of Left Ventricular Filling Pressures in Patients with Non ST-Elevation Myocardial Infarction
29. Cardiac myosin-binding protein C gene mutation expressed as hypertrophic cardiomyopathy and left ventricular noncompaction within two families: Insights from cardiac magnetic resonance in clinical screening: Camuglia MYBPC3 gene mutation and MRI
30. Transcatheter Aortic Valve Replacement as an Alternative to Redo-Surgical Aortic Valve Replacement for the Failing Aortic Bioprosthesis: Systematic Review and Meta-Analysis
31. Aortic Valve Calcium Scoring as a Predictor of Paravalvular Leakage in Transcatheter Aortic Valve Replacement
32. Acute Afterload Reduction Post–Transcatheter Aortic Valve Replacement: Early Mechanistic Insights into Improved Left Ventricular Performance
33. Case Report and Review: Epicardial Coronary Artery Fibromuscular Dysplasia
34. E/E’ Ratio as a Noninvasive Measure of Left Ventricular Filling Pressure in Patients with Non-ST-elevation Acute Coronary Syndromes (NSTEACS)
35. Novel Protocol to Facilitate Low Contrast Dose Computed Tomography Angiography Before Transcatheter Aortic Valve Replacement: Initial Experience
36. Cardiac catheterization is associated with superior outcomes for survivors of out of hospital cardiac arrest: Review and meta-analysis.
37. The Correlation Between Tei Index and Left Ventricular Filling Pressures in Patients with Non-ST elevation Acute Coronary Syndromes (NSTEACS)
38. Predicting Pre-A Wave LVEDP in Biomarker Positive Acute Coronary Syndrome using Lateral E/E′ and Tei Index
39. E/E′ Ratio as a Noninvasive Measure of Left Ventricular Filling Pressure in Patients with Non-ST-elevation Acute Coronary Syndromes (NSTEACS)
40. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies
41. Fractional Flow Reserve Assessment of Epicardial Coronary Artery Stenosis in the Setting of Severe Degenerative Valvular Aortic Stenosis
42. Spontaneous Coronary Artery Dissection: Presentation, Assessment, Treatment and Clinical Outcomes
43. Paclitaxel Drug Eluting Balloon: Analysis of Implementation for the Treatment of In-stent Restenosis and Side Branch Disease
44. Phenotypic Variability of Myosin Binding Protein C Gene Mutation Associated Cardiomyopathy: A Role for Cardiac Magnetic Resonance Imaging in Clinical Screening
45. Echocardiographic Parameters of Right Ventricular Dysfunction in Patients with Massive Pulmonary Embolism
46. Takayasu arteritis involving the left main coronary artery treated with a bioresorbable vascular scaffold.
47. Impact of Restrictive Filling on Ventricular Events in Patients with Ischaemic and Non-ischaemic Cardiomyopathy with Implantable Cardioverter-defibrillators
48. Impact of N-Acetylcysteine on Endothelial Function, B-type Natriuretic Peptide, and Renal Function in Patients with the Cardiorenal Syndrome: A Pilot Cross-over Randomised Controlled Trial
49. Positive Predictive Value of Exercise Electrocardiography in Patients Referred from a Brisbane Emergency Department with Chest Pain
50. Updated Society for Thoracic Surgeons Calculator Downgrades Surgical Risk Scores for Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR): Implications for TAVR and Patient re-stratification.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.